D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 90 Citations 36,089 396 World Ranking 6026 National Ranking 67

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Cancer
  • Disease

Jorma Paavonen focuses on Gynecology, Internal medicine, Chlamydia trachomatis, Cervical cancer and Cervical intraepithelial neoplasia. His biological study spans a wide range of topics, including Cancer, Clinical trial, Vaginal intraepithelial neoplasia, Obstetrics and Risk factor. His research integrates issues of Surgery, Sexually transmitted disease, Immunology and Vaccine efficacy in his study of Internal medicine.

His studies deal with areas such as Chlamydia, Cervicitis, Cervix, Pelvic inflammatory disease and Salpingitis as well as Chlamydia trachomatis. His study looks at the intersection of Cervical cancer and topics like Serology with Gold standard, Chlamydiae and CHLAMYDIAL INFECTIONS. His work deals with themes such as Genital warts, Cumulative incidence, Oncology and Vaccination, which intersect with Cervical intraepithelial neoplasia.

His most cited work include:

  • Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions (1649 citations)
  • Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. (1307 citations)
  • Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial (1140 citations)

What are the main themes of his work throughout his whole career to date?

Gynecology, Chlamydia trachomatis, Obstetrics, Internal medicine and Immunology are his primary areas of study. His Gynecology study which covers Cervix that intersects with Cervicitis. His Chlamydia trachomatis research incorporates elements of Chlamydia, Tubal factor infertility and Pelvic inflammatory disease.

His Obstetrics study also includes

  • Hysterectomy and related Levonorgestrel, Randomized controlled trial and Quality of life,
  • Cohort and related Cancer registry. His Internal medicine and Cervical cancer and Cervical intraepithelial neoplasia investigations all form part of his Internal medicine research activities. His Vaccination research includes elements of Clinical trial, Incidence, HPV infection and Human papillomavirus.

He most often published in these fields:

  • Gynecology (30.23%)
  • Chlamydia trachomatis (27.76%)
  • Obstetrics (25.29%)

What were the highlights of his more recent work (between 2013-2021)?

  • Obstetrics (25.29%)
  • Gynecology (30.23%)
  • Chlamydia trachomatis (27.76%)

In recent papers he was focusing on the following fields of study:

Jorma Paavonen mainly investigates Obstetrics, Gynecology, Chlamydia trachomatis, Internal medicine and Vaccination. His Obstetrics study combines topics from a wide range of disciplines, such as Odds ratio, Cohort, Retrospective cohort study, Placental abruption and Amniotic fluid. His Gynecology research also works with subjects such as

  • Breast cancer that intertwine with fields like Endometrial cancer,
  • Cephalic presentation most often made with reference to Foley catheter.

His Chlamydia trachomatis study incorporates themes from Tubal factor infertility and Antibody. Internal medicine is closely attributed to Oncology in his work. His Vaccination research is multidisciplinary, incorporating perspectives in Young adult, Randomized controlled trial, Cervical intraepithelial neoplasia and Hepatitis.

Between 2013 and 2021, his most popular works were:

  • Cancer Risk in Women Using the Levonorgestrel-Releasing Intrauterine System in Finland (113 citations)
  • Attribution of 12 High-Risk Human Papillomavirus Genotypes to Infection and Cervical Disease (105 citations)
  • Efficacy of Human Papillomavirus 16 and 18 (HPV-16/18) AS04-Adjuvanted Vaccine against Cervical Infection and Precancer in Young Women: Final Event-Driven Analysis of the Randomized, Double-Blind PATRICIA Trial (67 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Cancer
  • Disease

Jorma Paavonen focuses on Vaccination, Internal medicine, Gynecology, Randomized controlled trial and Young adult. His studies in Vaccination integrate themes in fields like Cervical cancer, Cervical intraepithelial neoplasia, HPV infection and Clinical trial. Particularly relevant to HPV vaccines is his body of work in Cervical cancer.

His Internal medicine research integrates issues from Surgery, Oncology and Vaccine efficacy. The Gynecology study combines topics in areas such as Miscarriage, Vaginal intraepithelial neoplasia, Colposcopy, Cancer registry and Obstetrics. His Young adult research includes themes of Papillomaviridae and Incidence.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions

Luisa L. Villa;Gonzalo Perez;Susanne K. Kjaer;Jorma Paavonen.
The New England Journal of Medicine (2007)

2710 Citations

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women.

J. Paavonen;P. Naud;J. Salmeron;C. M. Wheeler.
The Lancet (2009)

2128 Citations

Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial

Jorma Paavonen;David Jenkins;F. Xavier Bosch;Paulo Naud.
The Lancet (2007)

1784 Citations

A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection.

LA Koutsky;KK Holmes;CW Critchlow;CE Stevens.
The New England Journal of Medicine (1992)

1333 Citations

Once-Daily Valacyclovir to Reduce the Risk of Transmission of Genital Herpes

Lawrence Corey;Anna Wald;Raj Patel;Stephen L. Sacks.
The New England Journal of Medicine (2004)

866 Citations

Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial

Matti Lehtinen;Jorma Paavonen;Cosette M. Wheeler;Unnop Jaisamrarn.
Lancet Oncology (2012)

781 Citations

Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials

Elmar A Joura;Sepp Leodolter;Mauricio Hernandez-Avila;Cosette M Wheeler.
The Lancet (2007)

747 Citations

High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up

L. L. Villa;R. L. R. Costa;C. A. Petta;R. P. Andrade.
British Journal of Cancer (2006)

708 Citations

Chlamydia trachomatis: impact on human reproduction

J Paavonen;W Eggert-Kruse.
Human Reproduction Update (1999)

648 Citations

Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma.

Tarja Anttila;Pekka Saikku;Pentti Koskela;Aini Bloigu.
JAMA (2001)

584 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Jorma Paavonen

Joakim Dillner

Joakim Dillner

Karolinska University Hospital

Publications: 159

Suzanne M. Garland

Suzanne M. Garland

Royal Women's Hospital

Publications: 122

Matti Lehtinen

Matti Lehtinen

Karolinska Institute

Publications: 102

Mark Schiffman

Mark Schiffman

National Institutes of Health

Publications: 91

Anna Wald

Anna Wald

University of Washington

Publications: 77

Chris J.L.M. Meijer

Chris J.L.M. Meijer

Vrije Universiteit Amsterdam

Publications: 74

Eduardo L. Franco

Eduardo L. Franco

McGill University

Publications: 74

Anna R. Giuliano

Anna R. Giuliano

University of South Florida

Publications: 72

Lauri E. Markowitz

Lauri E. Markowitz

National Center for Immunization and Respiratory Diseases

Publications: 72

Wim Quint

Wim Quint

Erasmus University Rotterdam

Publications: 69

Susanne K. Kjaer

Susanne K. Kjaer

University of Copenhagen

Publications: 68

Rolando Herrero

Rolando Herrero

International Agency For Research On Cancer

Publications: 65

John T. Schiller

John T. Schiller

National Institutes of Health

Publications: 63

Allan Hildesheim

Allan Hildesheim

National Institutes of Health

Publications: 60

Elizabeth R. Unger

Elizabeth R. Unger

Centers for Disease Control and Prevention

Publications: 60

Silvia Franceschi

Silvia Franceschi

Centro di Riferimento Oncologico

Publications: 55

Trending Scientists

Reza Rejaie

Reza Rejaie

University of Oregon

Danyel Fisher

Danyel Fisher

Microsoft (United States)

Thomas F. Rutherford

Thomas F. Rutherford

University of Wisconsin–Madison

Hidenori Akiyama

Hidenori Akiyama

Fusiontech Corporation

Norio Miyaura

Norio Miyaura

Hokkaido University

Jacob J. Plattner

Jacob J. Plattner

Pfizer (United States)

Jukka Laine

Jukka Laine

Finnish Forest Research Institute

Peter W. Atkinson

Peter W. Atkinson

University of California, Riverside

Spyros Pournaras

Spyros Pournaras

National and Kapodistrian University of Athens

Shugui Hou

Shugui Hou

Nanjing University

G.H. Jones

G.H. Jones

Emory University

Jim Deuchars

Jim Deuchars

University of Leeds

Mark E. Walton

Mark E. Walton

University of Oxford

Fritz Hohagen

Fritz Hohagen

University of Lübeck

Marcus Taft

Marcus Taft

University of New South Wales

Carol R. Horowitz

Carol R. Horowitz

Icahn School of Medicine at Mount Sinai

Something went wrong. Please try again later.